27th Jun 2022
We last took a look at the patent landscape for solid-state batteries over three years ago, and since then, interest in the technology has only grown. Indeed, the massive rise in demand for electric vehicles has only served to further the future importance of solid-state batteries to automotive OEMs and battery manufacturers.
22nd Jun 2022
Since the regime was phased in from 1 April 2013, the UK Patent Box has enabled companies to apply a lower rate of Corporation Tax to worldwide profits earned from qualifying patented inventions and equivalent forms of intellectual property. The relief is given via a deduction from total taxable trading profits for a chargeable accounting period.
21st Jun 2022
Reddie & Grose is pleased to invite you to an online seminar which will guide you through the European Unitary Patent & Unified Patent Court (UPC). We will provide a detailed overview of the Unitary Patent system, including the UPC, and how the new system may affect your validation and litigation strategies. The Unitary Patent […]
21st Jun 2022
Reddie & Grose is pleased to invite you to an online seminar which will guide you through the European Unitary Patent & Unified Patent Court (UPC). We will provide a detailed overview of the Unitary Patent system, including the UPC, and how the new system may affect your validation and litigation strategies. The Unitary Patent […]
Biotechnology & Pharmaceuticals, Chemistry & Materials, Consumer Products & Manufacturing, Designs, Electronic & Electrical Devices, Featured News, IP news, Medical Devices & Digital Healthcare, Munich, Nederlands, R&G news, Technical Insights
10th Jun 2022
We are pleased to introduce our new newsletter, Sustainable Future: Exploring innovations for the Energy Transition and Circular Economy.
19th May 2022
Two recent decisions of the European Patent Office’s Boards of Appeal illustrate a risk faced by patent applications for artificial intelligence inventions: if the application does not describe the AI in enough detail then it can be refused for insufficient disclosure and lack of inventive step.
17th May 2022
The proposed European unitary patent system could come into force as early as this year, so it is important for patent owners to begin considering how they will make use of the new system, if at all. This article will explore some of the factors that organisations in the pharmaceutical sector should be considering in advance of the new system coming into effect.
11th May 2022
The European Patent Office (EPO) Guidelines relating to the patentability of Computer Implemented Inventions (CIIs) have been significantly amended following the publication of the seminal Enlarged Board of Appeal decision G1/19 on the patentability of computer simulations, reported here in 2021. The update places the T641/00 “COMVIK” approach at the centre of the test for patentability of CIIs, and includes a new discussion of its application to Artificial Intelligence inventions.